Stockhub

Aptorum Group Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

14 August 2022

11 August 2022

26 July 2022

  • curprev 18:2618:26, 26 July 2022‎ Chris talk contribs‎ 1,392 bytes +1,392‎ Created page with "Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including M..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Aptorum_Group_Limited’